- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Thalia Therapeutics PLC (THAT)
Thalia Therapeutics PLC stock price live, this page displays LON THAT stock exchange data. View the THAT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Thalia Therapeutics PLC real time stock price chart below.
What Is the Thalia Therapeutics PLC Stock Price Today?
The Thalia Therapeutics PLC stock price today is 0.625.
What Is the Stock Symbol for Thalia Therapeutics PLC?
The stock symbol for Thalia Therapeutics PLC is "THAT."
What Stock Exchange Does Thalia Therapeutics PLC Trade On?
Thalia Therapeutics PLC is listed and trades on the London stock exchange.
Is Thalia Therapeutics PLC a Good Stock to Buy?
Determining whether Thalia Therapeutics PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the THAT quote. (ISIN: GB00BYW8QM32)
What Is the Thalia Therapeutics PLC Stock Price Today?
The Thalia Therapeutics PLC stock price today is 0.625.
What Is the Stock Symbol for Thalia Therapeutics PLC?
The stock symbol for Thalia Therapeutics PLC is "THAT."
What Stock Exchange Does Thalia Therapeutics PLC Trade On?
Thalia Therapeutics PLC is listed and trades on the London stock exchange.
Is Thalia Therapeutics PLC a Good Stock to Buy?
Determining whether Thalia Therapeutics PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the THAT quote. (ISIN: GB00BYW8QM32)
London
Currency in GBP
0.625
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.600
0.639
52 wk Range
0.400
0.950
THAT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.6000.639
52 wk Range
0.4000.950
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
THAT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Thalia Therapeutics advances RNA therapy programs- Investing.com
- Thalia Therapeutics advances RNA therapy programs
- Investing.com
N4 Pharma changes name to Thalia Therapeutics- Investing.com
N4 Pharma plans name change to Thalia Therapeutics- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy
Earnings
Latest Release
Sep 24, 2026
EPS / Forecast
-- / --
Revenue / Forecast
3.64K / --
Compare THAT to Peers and Sector
Metrics to compare | THAT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTHATPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.6x | −5.3x | −0.3x | |
PEG Ratio | −0.30 | 0.01 | 0.00 | |
Price/Book | 4.5x | 1.8x | 2.6x | |
Price / LTM Sales | 1,538.0x | 2.2x | 2.9x | |
Upside (Analyst Target) | - | 133.0% | 64.3% | |
Fair Value Upside | Unlock | −6.7% | 9.9% | Unlock |
Thalia Therapeutics Plc, a biotechnology company, develops and delivers RNA-based therapeutics and technologies in oncology and cardiovascular disease in the United Kingdom. The company develops nanoparticle silica delivery systems to enhance the cellular delivery and potency of cancer treatments and vaccines. It also develops Nuvec, a pipeline of RNA therapeutics; and Liptide, a platform to deliver a proprietary siRNA sequence to silence a fibrotic gene. The company also engages in the development of N4 101, an orally delivered inflammation inhibitor for treatment of inflammatory bowel disease; and ECP105 for the prevention of ocular scarring. The company has collaboration with the Centre for Continuous Manufacturing and Advanced Crystallisation at the University of Strathclyde to support the scale-up and characterisation of Nuvec. The company was formerly known as N4 Pharma Plc and changed its name to Thalia Therapeutics Plc in March 2026. Thalia Therapeutics Plc was incorporated in 1979 and is based in London, the United Kingdom.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Thalia Therapeutics (THAT) Stock Price Today?
The Thalia Therapeutics stock price today is 0.625 GBP.
What Stock Exchange Does Thalia Therapeutics Trade On?
Thalia Therapeutics is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for Thalia Therapeutics?
The stock symbol for Thalia Therapeutics is "THAT."
What Is the Thalia Therapeutics Market Cap?
As of today, Thalia Therapeutics market cap is 11.100M GBP.
What Is Thalia Therapeutics's Earnings Per Share (TTM)?
The Thalia Therapeutics EPS (TTM) is -0.0017.
From a Technical Analysis Perspective, Is THAT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Thalia Therapeutics Stock Split?
Thalia Therapeutics has split 1 times.
How Many Employees Does Thalia Therapeutics Have?
Thalia Therapeutics has 3 employees.
What is the current trading status of Thalia Therapeutics (THAT)?
As of Oct 16, 2026, Thalia Therapeutics (THAT) is trading at a price of 0.625 GBP, with a previous close of 0.625 GBP. The stock has fluctuated within a day range of 0.600 GBP to 0.639 GBP, while its 52-week range spans from 0.400 GBP to 0.950 GBP.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.